Trump reversed a Biden order that sought to lower drug prices and make gene and cell therapies for cancer and other disease treatment available to Medicaid patients.
T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...
Atara Biotherapeutics said on Tuesday the U.S. health regulator has placed a clinical hold on its trials for cancer cell ...
Spravato is now the first-ever standalone therapy for treatment-resistant depression, and is on its way to becoming a ...
President Donald Trump’s choice for U.S. attorney general is declining to say how she plans to navigate key marijuana policy ...
The US Food and Drug Administration (FDA) has banned the commonly used food dye erythrosine, also known as Red 3, from food, ...
The boy's family believes his sickness was caused by an E. coli outbreak linked to romaine lettuce that affected 88 people ...
Atara Biotherapeutics (ATRA) stock slips as company faces an FDA clinical hold after rejection of lead candidate Ebvallo.
The U.S. Food and Drug Administration approved Johnson & Johnson's ketamine-based nasal spray Spravato, to treat adults with ...
Food companies criticize the science supporting front-of-package labeling, delay public consultation periods, push for their ...
Lilly has also submitted marketing applications for Mirikizumab-mrkz in Crohn’s disease around the globe, including in the ...
Cipla said that the United States Food and Drugs Administration (US FDA) has issued one observation in Form 483 to the manufacturing facility of its wholly-owned subsidiary Medispray Laboratories.